ArticleScience advances2022

A tumor vasculature-based imaging biomarker for predicting response and survival in patients with lung cancer treated with checkpoint inhibitors.

Mehdi Alilou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.